Leptin resistance in patients with chronic schizophrenia
Aim: Leptin is produced by the adipose tissue and reduces body weight by decreasing appetite and increasing metabolism. Patients treated with antipsychotics often have treatment-induced weight-gain, leading to other metabolic complications. Obese subjects often have leptin resistance, which is defin...
Main Authors: | Adam Wysokiński, Anna Dietrich-Muszalska |
---|---|
Format: | Article |
Language: | English |
Published: |
Medical Communications Sp. z o.o.
2019-06-01
|
Series: | Psychiatria i Psychologia Kliniczna |
Subjects: | |
Online Access: | http://www.psychiatria.com.pl/index.php/wydawnictwa/2019-vol-19-no-2/leptin-resistance-in-patients-with-chronic-schizophrenia?aid=850 |
Similar Items
-
Adipocytokines and Metabolic Syndrome in Patients with Schizophrenia
by: Irina A. Mednova, et al.
Published: (2020-10-01) -
PATHOGENETIC MECHANISMS OF LEPTIN RESISTANCE
by: G. A. Chumakova, et al.
Published: (2015-04-01) -
Serum leptin concentrations and telomere length in MDD and in controls
by: Owen M. Wolkowitz, et al.
Published: (2012-09-01) -
Leptin resistance: underlying mechanisms and diagnosis
by: Gruzdeva O, et al.
Published: (2019-01-01) -
The Role of Adiponectin in the Pathogenesis of Metabolic Disturbances in Patients With Schizophrenia
by: Cynthia Yi-An Chen, et al.
Published: (2021-01-01)